Literature DB >> 15671703

Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.

B Delia Johnson1, C Noel Bairey Merz, Glenn D Braunstein, Sarah L Berga, Vera Bittner, T Keta Hodgson, Gretchen L Gierach, Steven E Reis, Diane A Vido, Barry L Sharaf, Karen M Smith, George Sopko, Sheryl F Kelsey.   

Abstract

PURPOSE: Accurate classification of menopausal status is important to epidemiological research evaluating the role of reproductive hormones in disease processes. Algorithms relying on repeat hormone assays are unfeasible in large epidemiological studies. This paper summarizes the development of the Women's Ischemia Syndrome Evaluation (WISE) Hormonal menopausal status algorithm for determining premenopausal, perimenopausal, and postmenopausal status using menstrual and reproductive history and reproductive hormone levels obtained at a single clinic visit.
METHODS: The authors compared the accuracy of this algorithm with two currently used self-report algorithms: Menstrual, based only on months since last menstrual period, and Historical, which adds age and surgical history.
RESULTS: The study population consisted of 515 women (329 clearly postmenopausal) enrolled in the WISE study who were undergoing coronary angiography for suspected ischemia. A subgroup of 186, not clearly postmenopausal, was classified by these three algorithms. Results were evaluated against individualized expert consensus classification. The Menstrual and Historical classifications differed significantly (p < 0.0001) from expert consensus, with 32%-26% discordant classifications, respectively. For the WISE Hormonal classification, discordance was 4%.
CONCLUSIONS: The authors conclude that inaccurate classifications of menopausal status occur frequently in self-report algorithms. Use of the relatively simple WISE algorithm can improve the accuracy of menopausal status classification for epidemiological research.

Entities:  

Mesh:

Year:  2004        PMID: 15671703     DOI: 10.1089/jwh.2004.13.872

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  36 in total

1.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  J Clin Endocrinol Metab       Date:  2012-02-16       Impact factor: 5.958

Review 2.  Menstruation and the menopausal transition.

Authors:  Siobán D Harlow; Pangaja Paramsothy
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

3.  The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study.

Authors:  B Delia Johnson; Kathleen M Dwyer; Frank Z Stanczyk; Vera Bittner; Sarah L Berga; Glenn D Braunstein; Ricardo Azziz; YuChing Yang; Georgina E Hale; C Noel Bairey Merz
Journal:  J Clin Endocrinol Metab       Date:  2010-06-16       Impact factor: 5.958

4.  Atorvastatin increases exercise leg blood flow in healthy adults.

Authors:  Beth A Parker; Jeffrey A Capizzi; Amanda L Augeri; Adam S Grimaldi; C Michael White; Paul D Thompson
Journal:  Atherosclerosis       Date:  2011-10-04       Impact factor: 5.162

5.  FSH Levels Predict Bone Loss in Premenopausal Women Treated for Breast Cancer More Than One Year After Treatment.

Authors:  Laila S Tabatabai; Joan Bloom; Susan Stewart; Deborah E Sellmeyer
Journal:  J Clin Endocrinol Metab       Date:  2016-01-12       Impact factor: 5.958

6.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  Fertil Steril       Date:  2012-02-16       Impact factor: 7.329

7.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  Menopause       Date:  2012-04       Impact factor: 2.953

8.  Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question.

Authors:  C Noel Bairey Merz; Chrisandra Shufelt; B Delia Johnson; Ricardo Azziz; Glenn D Braunstein
Journal:  Maturitas       Date:  2010-01-22       Impact factor: 4.342

9.  Assessing the utility of methods for menopausal transition classification in a population-based cohort: the CARDIA Study.

Authors:  Hilary K Whitham; Richard F Maclehose; Bernard L Harlow; Melissa F Wellons; Pamela J Schreiner
Journal:  Maturitas       Date:  2013-05-22       Impact factor: 4.342

10.  Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  C Noel Bairey Merz; B Delia Johnson; Sarah L Berga; Glenn D Braunstein; Ricardo Azziz; Yuching Yang; Steven E Reis; Vera Bittner; T Keta Hodgson; Carl J Pepine; Barry L Sharaf; George Sopko; Sheryl F Kelsey
Journal:  J Womens Health (Larchmt)       Date:  2009-09       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.